Neuroendocrine Carcinoma Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
Le carcinome neuroendocrinien est un type de tumeur qui prend naissance dans les cellules productrices d'hormones des systèmes neuroendocriniens constitués du système endocrinien et du système nerveux. Ces cellules neuroendocrines se trouvent dans tout le corps, y compris les reins, les intestins, l'estomac, etc. Certains symptômes courants du carcinome neuroendocrinien sont l'hyperglycémie, la perte de poids, la jaunisse, la fièvre, l'anxiété, les maux de tête, etc.
DYNAMIQUE DU MARCHÉ
Le marché du carcinome neuroendocrinien devrait croître selon les prévisions, en raison de facteurs tels que la demande croissante de carcinome neuroendocrinien, le nombre croissant d'essais cliniques, l'exploration de technologies de séquençage de nouvelle génération, l'augmentation des partenariats pour renforcer les produits. portefeuilles, augmentant les investissements en R&D et les approbations réglementaires rapides. Néanmoins, le coût élevé du traitement devrait entraver la croissance du marché au cours de la période de prévision.
ÉTENDUE DU MARCHÉ
L'analyse du marché mondial du carcinome neuroendocrinien jusqu'en 2031 est une étude spécialisée et approfondie de l'industrie pharmaceutique avec un accent particulier sur le marché mondial. analyse des tendances du marché. Le rapport vise à fournir un aperçu du marché du carcinome neuroendocrinien avec une segmentation détaillée du marché par type d’indication, type de traitement, utilisateur final et géographie. Le marché mondial du carcinome neuroendocrinien devrait connaître une forte croissance au cours de la période de prévision. Le rapport fournit des statistiques clés sur l'état du marché des principaux acteurs du marché du carcinome neuroendocrinien et présente les principales tendances et opportunités sur le marché.
SEGMENTATION DU MARCHÉ
Le rapport mondial sur le carcinome neuroendocrinien Le marché du carcinome est segmenté en fonction du type d’indication, du type de traitement et de l’utilisateur final. En fonction du type d’indication, le marché est segmenté en tumeurs neuroendocrines gastriques, tumeurs neuroendocrines du poumon, tumeurs neuroendocrines pancréatiques, tumeurs neuroendocrines appendiculaires. En fonction du type de traitement, le marché est segmenté en chimiothérapie, antimétabolites, agents alkylants, produits naturels, thérapie ciblée, inhibiteur de la tyrosine kinase, inhibiteur de mTOR, analogues de la somatostatine. En fonction de l’utilisateur final, le marché est segmenté en hôpitaux, cliniques, centres d’oncologie et centres chirurgicaux ambulatoires.
Neuroendocrine Carcinoma Market: Strategic Insights
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- F Hoffmann La Roche Ltd
- Pfizer Inc
- Novartis AG
- LEXICON PHARMACEUTICALS INC
- Amgen Inc
- AbbVie Inc
- Ipsen Pharma
- Mateon Therapeutics Inc
- Mallinckrodt
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
- tumeur neuroendocrine gastrique
- tumeurs neuroendocrines du poumon
- tumeurs neuroendocrines pancréatiques
- tumeurs neuroendocrines appendiculaires
- chimiothérapie
- antimétabolites
- agents alkylants
- produits naturels
- thérapie ciblée
- inhibiteur de la tyrosine kinase
- inhibiteur de mTOR
- analogues de la somatostatine
- hôpitaux
- cliniques
- centres d'oncologie
- centres chirurgicaux ambulatoires
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Le rapport fournit un aperçu détaillé de l'industrie, comprenant des informations à la fois qualitatives et quantitatives. Il fournit un aperçu et des prévisions du marché mondial du carcinome neuroendocrinien en fonction de divers segments. Il fournit également la taille du marché et des estimations prévisionnelles de 2021 à 2031 pour cinq grandes régions, à savoir : Amérique du Nord, Europe, Asie-Pacifique (APAC), Moyen-Orient et Afrique (MEA) et Amérique du Sud et du Sud. Amérique centrale. Le marché du carcinome neuroendocrinien de chaque région est ensuite sous-segmenté par pays et segments respectifs. Le rapport couvre l'analyse et les prévisions de 18 pays dans le monde ainsi que les tendances actuelles et les opportunités qui prévalent dans la région.
Le rapport analyse les facteurs affectant le marché du carcinome neuroendocrinien du côté de la demande et de l'offre et évalue plus en détail la dynamique du marché affectant le marché du carcinome neuroendocrinien. marché au cours de la période de prévision, c’est-à-dire les moteurs, les contraintes, les opportunités et les tendances futures. Le rapport fournit également une analyse PEST exhaustive pour les cinq régions, à savoir : Amérique du Nord, Europe, APAC, MEA et Amérique du Sud et du Sud. Amérique centrale après avoir évalué les facteurs politiques, économiques, sociaux et technologiques affectant le marché du carcinome neuroendocrinien dans ces régions.
ACTEURS DU MARCHÉ
Le les rapports couvrent les développements clés du marché du carcinome neuroendocrinien en tant que stratégies de croissance organique et inorganique. Diverses entreprises se concentrent sur des stratégies de croissance organique telles que les lancements de produits, les approbations de produits et d'autres telles que les brevets et les événements. Les activités de stratégies de croissance inorganiques observées sur le marché étaient des acquisitions et des partenariats et des partenariats. collaborations. Ces activités ont ouvert la voie à l’expansion des activités et de la clientèle des acteurs du marché. Les payeurs du marché du carcinome neuroendocrinien devraient offrir des opportunités de croissance lucratives à l’avenir avec la demande croissante pour le marché du carcinome neuroendocrinien sur le marché mondial. Vous trouverez ci-dessous la liste de quelques entreprises engagées sur le marché du carcinome neuroendocrinien.
Le rapport comprend également les profils des sociétés du marché du carcinome neuroendocrinien ainsi que leur analyse SWOT et leurs stratégies de marché. En outre, le rapport se concentre sur les principaux acteurs de l'industrie avec des informations telles que les profils d'entreprise, les composants et services proposés, les informations financières des 3 dernières années, les développements clés au cours des cinq dernières années.
- F. Hoffmann-La Roche Ltd
- Pfizer Inc
- Novartis AG
- LEXICON PHARMACEUTICALS, INC
- Amgen Inc
- AbbVie Inc
- Ipsen Pharma
- Mateon Therapeutics, Inc
- Mallinckrodt
- CELGENE CORPORATION
Neuroendocrine Carcinoma Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ XX million |
Market Size by | US$ XX Million |
Global CAGR | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Type d'indication
|
Regions and Countries Covered |
Amérique du Nord
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
- F. Hoffmann-La Roche Ltd
- Pfizer Inc
- Novartis AG
- LEXICON PHARMACEUTICALS, INC
- Amgen Inc
- AbbVie Inc
- Ipsen Pharma
- Mateon Therapeutics, Inc
- Mallinckrodt
- CELGENE CORPORATION
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.